World’s largest autism grant will transform research landscape
27 September 2020
The largest research grant ever given for neurodevelopmental conditions has been awarded by the Innovative Medicines Initiative to an international consortium academically led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London.
MSc Clinical & Therapeutic Neuroscience: Class 2019/20 Prizes
22 September 2020
Congratulations to our MSc in Clinical and Therapeutic Neuroscience, Class of 2019/20 for successfully completing the course.
Scientists discover what happens in our brains when we make educated guesses
17 September 2020
Researchers have identified how cells in our brains work together to join up memories of separate experiences, allowing us to make educated guesses in everyday life.
Raised blood pressure and diabetes alter brain structure
7 September 2020
In a new study, neuroscientists have found that raised blood pressure and diabetes in mid-life alter brain structure to slow thinking speed and memory.
Royal Academy of Engineering Fellowship for Yuriko Suzuki
14 August 2020
Integrative Neuroimaging Research
Dr Suzuki's award will support her work on robust visualisation of blood vessels in patients with vessel-narrowing disease
Scientists uncover the role of neuronal networks in moving between wake and sleep states
13 August 2020
Changes in the way that neurons communicate with each other affect our ability to move between sleep and wake states.
NDCN awarded Athena SWAN Silver Renewal
5 August 2020
NDCN has been awarded a renewal of its Athena SWAN Silver Award. This award is a strong endorsement of NDCN’s work to improve gender equality and build a positive research culture.
Recent DPhil student begins fellowship to study causes of motor neuron disease
28 July 2020
The Medical Research Council has awarded Alexander Thompson a prestigious five-year Lady Edith Wolfson MRC Clinician Scientist Fellowship to investigate the causes of amyotrophic lateral sclerosis (ALS, also known as motor neuron disease, MND).
Professor Robert MacLaren receives Innovation Award
27 July 2020
Professor Robert MacLaren is the winner of the Inspiring Leadership category in the Vice-Chancellor's Innovation Awards 2020 for his work on Nightstar, a retinal gene therapy company.
Seminar Summary: Interventions for improving chronic sleep disruption
22 July 2020
DPhil student Lampros Bisdounis summarises a departmental seminar by Associate Professor Simon Kyle
Six-month outcomes after treatment for COVID-19 on intensive care units in England
21 July 2020
Anaesthetics Coronavirus Research
Researchers at the University of Oxford are investigating the long-term health outcomes for patients who have been treated for severe COVID-19 disease in intensive care. Finding out whether these outcomes differ from those of other patients who have survived critical care will help to inform clinical practice and appropriate follow-up care.
New COVID-19 simulation training for smartphones helps African healthcare workers save lives
6 July 2020
Anaesthetics Coronavirus Research
The University of Oxford's LIFE project has launched a new set of app-based training scenarios that help healthcare workers in Africa safely manage and treat cases of children with suspected COVID-19
Sleep disruption after brain injury is linked to slower recovery
23 June 2020
Integrative Neuroimaging Research
Our researchers discover new evidence that post-brain injury sleep problems can slow the pace of recovery.
Motorsport technology helps keep COVID-19 clinicians safe
18 June 2020
Staff at our Oxford Simulation,Teaching & Research centre (OxSTaR) helped to develop this new type of aerosol shield designed by Formula One motor racing engineers
Effects of COVID-19 on sleep: Oxford researchers lead international study
11 June 2020
Coronavirus Ophthalmology Research SCNi
An international group of researchers led by Professor Colin Espie is investigating the impact of the COVID-19 pandemic on sleep and daily rhythms in adults.
Oxford leads part of major COVID-19 drugs trial
10 June 2020
Anaesthetics Coronavirus Research
As part of the UK NIHR multi-arm, multi-stage CATALYST Trial, researchers at the University of Oxford will investigate whether administering the anti-inflammatory drug infliximab to patients with COVID-19 can prevent progression to respiratory failure or death.
COVID-19 drug trial could lead to enhanced respiratory care for patients
29 May 2020
Anaesthetics Coronavirus Research
Researchers including Stuart McKechnie and Matthew Rowland from our Critical Care Research Group are carrying out a new drug trial aimed at treating COVID-19, funded by LifeArc.
Seminar Summary: What is the problem with diffusion MR data - and what do we do about it?
28 May 2020
Integrative Neuroimaging Research
Post-doctoral Researcher Michiel Cottaar summarises a departmental seminar by Associate Professor Jesper Andersson